Houston Methodist Hospital- Department of Urology — Houston, Texas

Houston Methodist Hospital- Department of Urology is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Houston Methodist Hospital- Department of Urology has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer, Superficial Bladder Cancer.

Sponsors: QED Therapeutics, a BridgeBio company, enGene, Inc., Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Houston Methodist Hospital- Department of Urology?

Houston Methodist Hospital- Department of Urology has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Houston Methodist Hospital- Department of Urology conducted?

Houston Methodist Hospital- Department of Urology has 3 clinical trials on record, with 2 currently active. Their work covers Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer, Superficial Bladder Cancer.

Is Houston Methodist Hospital- Department of Urology accredited by Crixeo Clinical Trials?

Houston Methodist Hospital- Department of Urology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Houston Methodist Hospital- Department of Urology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.